Clinical Data to Present at the Noble Financial Fourth Annual Equity Conference in Las Vegas.NEWTON, Mass. -- Clinical Data, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CLDA CLDA California Lyme Disease Association ), a leader in the development of targeted therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that it will present at the at the upcoming Noble Financial Fourth Annual Equity Conference which will be held Monday Monday: see week. , August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Lake Las Vegas is located in Henderson, Nevada. Lake Las Vegas refers to both a man made 320 acre (0 km) lake and to the area built around the lake. The area is sometimes referred to as the Lake Las Vegas Resort. Resort, NV. Drew Fromkin, President and Chief Executive Officer will discuss the Company's business strategy and historical financial performance at 1:30 p.m. Pacific Time on Monday, August 18th. A live audio webcast of Clinical Data's presentation may be accessed through the Company's website at www.clda.com. An archived replay of the presentation will be available after the live presentation, and can also be accessed at www.clda.com. About Clinical Data, Inc. Clinical Data, Inc. is unlocking the potential of molecular discovery from Targeted Science to Better Healthcare[TM]. Its PGxHealth([R]) division focuses on proprietary biomarker biomarker /bio·mark·er/ (bi´o-mahr?ker) 1. a biological molecule used as a marker for a substance or process of interest. 2. tumor marker. bi·o·mark·er n. 1. and pharmacogenetic test development as well as targeted therapeutics to help predict drug safety and efficacy, thereby reducing health care costs and improving clinical outcomes. Its Cogenics([R]) division provides genomics services to both research and regulated environments. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. Visit the Company's website at www.clda.com for more information. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion